Loading…
MED Holdings accelerates drug commercialization and improves patient outcomes by redefining copayment enablement for local patient support programs. The company focuses on removing friction in market access, particularly in emerging Asia Pacific, to ensure innovative medicines are rapidly accessible to all.
AI named MedScore in December 2025.